Mersana Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRSN and other ETFs, options, and stocks.

About MRSN

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing antibody drug conjugates that offer clinical benefit for cancer patients with significant unmet need. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. 

CEO
Anna Protopapas
CEOAnna Protopapas
Employees
169
Employees169
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2001
Founded2001
Employees
169
Employees169

MRSN Key Statistics

Market cap
657.84M
Market cap657.84M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.13M
Average volume1.13M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$10.01
52 Week high$10.01
52 Week low
$2.68
52 Week low$2.68

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

MRSN Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.